This may possibly be explained by lower NK cell cytotoxicity in the presence of this KIR-ligand combination as shown in a study of 1277 patients treated with allogeneic hematopoetic stem cell transplantation for myeloid leukemia. Here, KIR3DL1 is linked to myeloid leukemia.